NICOLE BELL: Open Payments
NPI 1366844649 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 39 payments from 10 companies in 2025. Trend: 2023 $856 · 2024 $670 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $148 |
| Astellas Pharma US Inc | 7 | $147 |
| Sage Therapeutics, LLC | 5 | $118 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $114 |
| Organon LLC | 4 | $88 |
| MILLICENT US INC | 3 | $70 |
| Exeltis, USA Inc. | 3 | $58 |
| OptumHealth Care Solutions, LLC | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $22 |
Products named: Veozah, MYFEMBREE, ZURZUVAE, NEXPLANON, SLYND, FEMRING, VIVIFY HEALTH CARE TEAM PORTAL 001, EVENITY.
Industry payments across OH — which companies pay providers there.
